Literature DB >> 17353226

Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia.

An-Tao Du1, Norbert Schuff, Joel H Kramer, Howard J Rosen, Maria Luisa Gorno-Tempini, Katherine Rankin, Bruce L Miller, Michael W Weiner.   

Abstract

Alzheimer's disease and frontotemporal dementia (FTD) can be difficult to differentiate clinically because of overlapping symptoms. Distinguishing the two dementias based on volumetric measurements of brain atrophy with MRI has been only partially successful. Whether MRI measurements of cortical thinning improve the differentiation between Alzheimer's disease and FTD is unclear. In this study, we measured cortical thickness using a set of automated tools (Freesurfer) to reconstruct the brain's cortical surface from T1-weighted structural MRI data in 22 patients with Alzheimer's disease, 19 patients with FTD and 23 cognitively normal subjects. The goals were to detect the characteristic patterns of cortical thinning in these two types of dementia, to test the relationship between cortical thickness and cognitive impairment, to determine if measurement of cortical thickness is better than that of cortical volume for differentiating between these dementias and normal ageing and improving the classification of Alzheimer's disease and FTD based on neuropsychological scores alone. Compared to cognitively normal subjects, Alzheimer's disease patients had a thinner cortex primarily in bilateral, frontal, parietal, temporal and occipital lobes (P < 0.001), while FTD patients had a thinner cortex in bilateral, frontal and temporal regions and some thinning in inferior parietal regions and the posterior cingulate (P < 0.001). Compared to FTD patients, Alzheimer's disease patients had a thinner cortex (P < 0.001) in parts of bilateral parietal and precuneus regions. Cognitive impairment was negatively correlated with cortical thickness of frontal, parietal and temporal lobes in Alzheimer's disease, while similar correlations were not significant in FTD. Measurement of cortical thickness was similar to that of cortical volume in differentiating between normal ageing, Alzheimer's disease and FTD. Furthermore, cortical thickness measurements significantly improved the classification between Alzheimer's disease and FTD based on neuropsychological scores alone, including the Mini-Mental State Examination and a modified version of the Trail-Making Test. In conclusion, the characteristic patterns of cortical thinning in Alzheimer's disease and FTD suggest that cortical thickness may be a useful surrogate marker for these types of dementia.

Entities:  

Mesh:

Year:  2007        PMID: 17353226      PMCID: PMC1853284          DOI: 10.1093/brain/awm016

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  36 in total

1.  What's in a name: voxel-based morphometric analyses of MRI and naming difficulty in Alzheimer's disease, frontotemporal dementia and corticobasal degeneration.

Authors:  Murray Grossman; Corey McMillan; Peachie Moore; Lijun Ding; Guila Glosser; Melissa Work; James Gee
Journal:  Brain       Date:  2004-02-04       Impact factor: 13.501

2.  Lateralization on neuroimaging does not differentiate frontotemporal lobar degeneration from Alzheimer's disease.

Authors:  Anne M Lipton; Raul Benavides; Linda S Hynan; Frederick J Bonte; Thomas S Harris; Charles L White; Eileen H Bigio
Journal:  Dement Geriatr Cogn Disord       Date:  2004       Impact factor: 2.959

3.  Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease.

Authors:  T Gómez-Isla; J L Price; D W McKeel; J C Morris; J H Growdon; B T Hyman
Journal:  J Neurosci       Date:  1996-07-15       Impact factor: 6.167

4.  Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices.

Authors:  D A Lewis; M J Campbell; R D Terry; J H Morrison
Journal:  J Neurosci       Date:  1987-06       Impact factor: 6.167

5.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.

Authors:  E R DeLong; D M DeLong; D L Clarke-Pearson
Journal:  Biometrics       Date:  1988-09       Impact factor: 2.571

6.  Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease.

Authors:  R C Pearson; M M Esiri; R W Hiorns; G K Wilcock; T P Powell
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

Review 7.  Staging of Alzheimer's disease-related neurofibrillary changes.

Authors:  H Braak; E Braak
Journal:  Neurobiol Aging       Date:  1995 May-Jun       Impact factor: 4.673

8.  The Clinical Dementia Rating (CDR): current version and scoring rules.

Authors:  J C Morris
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

9.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

10.  The topographic distribution of brain atrophy in frontal lobe dementia.

Authors:  D M Mann; P W South
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

View more
  179 in total

1.  Discriminant analysis of longitudinal cortical thickness changes in Alzheimer's disease using dynamic and network features.

Authors:  Yang Li; Yaping Wang; Guorong Wu; Feng Shi; Luping Zhou; Weili Lin; Dinggang Shen
Journal:  Neurobiol Aging       Date:  2011-01-26       Impact factor: 4.673

2.  Default network correlations analyzed on native surfaces.

Authors:  Tyler M Seibert; James B Brewer
Journal:  J Neurosci Methods       Date:  2011-04-14       Impact factor: 2.390

Review 3.  Quantitative structural MRI for early detection of Alzheimer's disease.

Authors:  Linda K McEvoy; James B Brewer
Journal:  Expert Rev Neurother       Date:  2010-11       Impact factor: 4.618

4.  Hippocampal hyperactivation associated with cortical thinning in Alzheimer's disease signature regions in non-demented elderly adults.

Authors:  Deepti Putcha; Michael Brickhouse; Kelly O'Keefe; Caroline Sullivan; Dorene Rentz; Gad Marshall; Brad Dickerson; Reisa Sperling
Journal:  J Neurosci       Date:  2011-11-30       Impact factor: 6.167

5.  Cortical gray matter atrophy in healthy aging cannot be explained by undetected incipient cognitive disorders: a comment on Burgmans et al. (2009).

Authors:  Anders M Fjell; Lars T Westlye; Thomas Espeseth; Ivar Reinvang; Anders M Dale; Dominic Holland; Kristine B Walhovd
Journal:  Neuropsychology       Date:  2010-03       Impact factor: 3.295

6.  Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort.

Authors:  Shannon L Risacher; Li Shen; John D West; Sungeun Kim; Brenna C McDonald; Laurel A Beckett; Danielle J Harvey; Clifford R Jack; Michael W Weiner; Andrew J Saykin
Journal:  Neurobiol Aging       Date:  2010-08       Impact factor: 4.673

7.  Graph-guided joint prediction of class label and clinical scores for the Alzheimer's disease.

Authors:  Guan Yu; Yufeng Liu; Dinggang Shen
Journal:  Brain Struct Funct       Date:  2015-10-17       Impact factor: 3.270

8.  Morphologic and neuropsychological patterns in patients suffering from Alzheimer's disease.

Authors:  Pierre Chapuis; Mathilde Sauvée; Maud Medici; Amélie Serra; Eldda Banciu; Alexandre Moreau-Gaudry; Olivier Moreaud; Alexandre Krainik
Journal:  Neuroradiology       Date:  2016-02-15       Impact factor: 2.804

9.  The power of neuroimaging biomarkers for screening frontotemporal dementia.

Authors:  Corey T McMillan; Brian B Avants; Philip Cook; Lyle Ungar; John Q Trojanowski; Murray Grossman
Journal:  Hum Brain Mapp       Date:  2014-03-31       Impact factor: 5.038

10.  Perfusion alterations converge with patterns of pathological spread in transactive response DNA-binding protein 43 proteinopathies.

Authors:  Pilar M Ferraro; Charles Jester; Christopher A Olm; Katerina Placek; Federica Agosta; Lauren Elman; Leo McCluskey; David J Irwin; John A Detre; Massimo Filippi; Murray Grossman; Corey T McMillan
Journal:  Neurobiol Aging       Date:  2018-04-17       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.